Common Surgical Procedures Account for High Share of Opioid Prescriptions in Children and Adults
July 11th 2024In pediatric and adult patients, the top 3 surgical procedures accounted for the highest share of opioid prescriptions, indicating a need for better opioid prescription management and greater awareness of the possible opioid-related adverse events that can stem from prescriptions of the drug.
Read More
FTC Intends to Sue Biggest Pharmacy Benefit Managers for Unfair Negotiating Tactics
July 11th 2024In a follow-up to the interim FTC report documenting the business practices of PBMs and the power they hold in the pharmaceutical industry, the Commission now seeks to sue the 3 largest PBMs in the country for driving up the price of insulin and other essential drugs.
Read More
High-Dose Intravenous Immunoglobulin Responsive to Platelet-Activating Anti-PF4 Disorder
July 11th 2024Intravenous immunoglobulin was effective as an adjunctive treatment to anticoagulation in a patient with post-viral platelet-activating anti-PF4 disorder, indicating the need for accurate diagnosis and treatment selection.
Read More
Understand the Effects of Topical Nasal Decongestants on Blood Pressure
Because decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
Read More
Brexanolone and Zuranolone for the Treatment of Postpartum Depression
July 9th 2024The American College of Clinical Gynecology recommends consideration of brexanolone or zuranolone in postpartum patients with onset of moderate-to-severe perinatal depression in the third trimester or within 4 weeks postpartum.
Read More
Prefilled Syringe of Faricimab-Svoa Approved by FDA for Leading Causes of Vision Loss
July 8th 2024Following the previous FDA approval of faricimab-svoa to treat some of the leading causes of vision loss, the Administration has approved a single-dose prefilled syringe of the drug which could lead to safer and more efficient administration while easing patient burden.
Read More